Audited Financial Results for the Quarter and Year ended March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natural Biocon (India) Ltd reported a net loss of Rs. 4.00 lakhs for FY26, a sharp reversal from a profit of Rs. 2.46 lakhs in FY25. Total income dropped to Rs. 254.54 lakhs from Rs. 834.81 lakhs in the prior year, representing a roughly 70% revenue decline. The company posted a Q4 loss of Rs. 0.39 lakhs on revenue of Rs. 87.85 lakhs. The statutory auditor Mayur Shah & Associates issued an unmodified opinion but highlighted multiple red flags: the auditor resigned on 14-02-2026 which management has not accepted; funds from a Rs. 19.45 crore preferential allotment (July 2024) meant for working capital were diverted into investments; key account balances could not be verified due to missing confirmations; and share certificates for investments were not received. Cash flow from operations was positive at Rs. 2.90 lakhs but remains minimal.
The sharp revenue decline and transition to loss, combined with auditor resignation and fund diversion concerns, signal elevated risk. The unmodified opinion masks serious audit reservations that investors should carefully review before making decisions.